Safety and efficacy of pazopanib (PAZ) in advanced soft tissue carcinoma (aSTS) by prior lines of therapy, age, and dose modifications: PALETTE subgroup analyses

Authors :: Hans Gelderblom
A. Le Cesne
Qasim Ahmad
G.D.S. Demetri
G. Han
Luca Dezzani
W.T.A. van der Graaf
Sebastian Bauer
Source :: Annals of Oncology. 28:v530-v531
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
Pathology
business.industry
Hematology
Pazopanib
03 medical and health sciences
0302 clinical medicine
Palette (painting)
030220 oncology & carcinogenesis
Internal medicine
medicine
030212 general & internal medicine
Soft tissue carcinoma
business
medicine.drug

Tools